NOVAVAX INC's ticker is NVAXXXXX and the CUSIP is 670002104. A total of 130 filers reported holding NOVAVAX INC in Q2 2017. The put-call ratio across all filers is 1.26 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $4,000 | -33.3% | 2,200 | -31.2% | 0.00% | – |
| Q3 2018 | $6,000 | +100.0% | 3,200 | +45.5% | 0.00% | – |
| Q2 2018 | $3,000 | -40.0% | 2,200 | 0.0% | 0.00% | – |
| Q1 2018 | $5,000 | +66.7% | 2,200 | 0.0% | 0.00% | – |
| Q4 2017 | $3,000 | 0.0% | 2,200 | 0.0% | 0.00% | – |
| Q3 2017 | $3,000 | 0.0% | 2,200 | 0.0% | 0.00% | – |
| Q2 2017 | $3,000 | 0.0% | 2,200 | 0.0% | 0.00% | – |
| Q1 2017 | $3,000 | -40.0% | 2,200 | 0.0% | 0.00% | -100.0% |
| Q3 2016 | $5,000 | -68.8% | 2,200 | 0.0% | 0.00% | -75.0% |
| Q2 2016 | $16,000 | +1500.0% | 2,200 | +1000.0% | 0.00% | – |
| Q1 2016 | $1,000 | -50.0% | 200 | 0.0% | 0.00% | -100.0% |
| Q4 2015 | $2,000 | +100.0% | 200 | 0.0% | 0.00% | – |
| Q3 2015 | $1,000 | -75.0% | 200 | -60.0% | 0.00% | -100.0% |
| Q4 2014 | $4,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 8,330,000 | $10,496,000 | 0.39% |
| Alden Global Capital LLC | 640,500 | $807,000 | 0.28% |
| Quantitative Investment Management, LLC | 3,784,100 | $4,767,000 | 0.12% |
| Eventide Asset Management | 1,449,700 | $1,827,000 | 0.12% |
| Bellevue Group AG | 325,000 | $410,000 | 0.08% |
| Virtus ETF Advisers LLC | 196,162 | $247,000 | 0.07% |
| Rock Springs Capital Management LP | 820,000 | $1,033,000 | 0.07% |
| Quantbot Technologies LP | 462,250 | $582,000 | 0.06% |
| Traynor Capital Management, Inc. | 43,361 | $55,000 | 0.04% |
| Tekla Capital Management LLC | 571,000 | $719,000 | 0.03% |